Full TrumpRx Drug List 2026: Discounted Prices, Eligibility & Complete Guide

The launch of TrumpRx marks one of the most significant developments in U.S. prescription drug policy in recent memory. Unveiled on February 5, 2026, the platform aims to deliver what the administration calls “the world’s lowest prices on prescription drugs” to American consumers .

By facilitating direct-to-consumer access to pre-negotiated manufacturer discounts, TrumpRx drug list seeks to address a long-standing grievance: that Americans have effectively subsidized global drug prices .

Early reports indicate the program has already expanded significantly from its initial rollout, now offering discounts on more than 60 brand-name medications from major pharmaceutical companies . This includes some of the most talked-about and expensive drugs on the market, such as the weight-loss and diabetes medications Wegovy, Ozempic, and Zepbound .

However, as with any major healthcare initiative, understanding the specifics is crucial. Who does TrumpRx actually help? What are its limitations? And most importantly, for the average American, is this a better deal than what their current insurance provides?

How TrumpRx Works: The Mechanics Behind the Discounts

Before diving into the list of drugs and who qualifies, it’s essential to understand what TrumpRx is and, perhaps more importantly, what it is not.

A Platform, Not a Pharmacy

TrumpRx is not a government-run pharmacy that dispenses medications . Instead, it functions as a centralized directory and coupon generator. Patients with a valid prescription can visit the website, search for their medication, and view a discounted cash price alongside the usual U.S. list price .

From there, the platform either provides a digital or printable coupon to present at a local pharmacy or redirects the patient to a pharmaceutical company’s direct-to-consumer (DTC) purchase website .

The Trade Agreement

The deep discounts available on TrumpRx are not simply acts of corporate goodwill. They are the result of explicit policy deals between the Trump administration and participating drug companies. These agreements often require manufacturers to lower U.S. prices for select drugs to match the lowest net price paid in a group of peer countries like Canada, the U.K., and Germany .

In exchange, the companies receive strategic benefits, such as exemptions from threatened tariffs on pharmaceutical imports . Economist John C. Goodman highlights this as a “real negotiation,” distinct from the price-fixing he attributes to the previous administration’s approach.

Who TrumpRx Actually Helps

The program is not designed for everyone. Its benefits are most acutely felt by specific segments of the population who face the most significant barriers to affording medication.

1. The Uninsured Population

For the roughly 8% of non-elderly Americans without health insurance, TrumpRx could be a genuine lifeline . The difference between paying a drug’s full list price and its discounted cash price can be the deciding factor between receiving treatment and going without . For example, seeing a drug like Wegovy drop from over $1,300 to around $200 per month can make previously inaccessible treatments a reality .

2. Individuals in High-Deductible Health Plans

With over 50% of covered workers enrolled in high-deductible health plans, many Americans face substantial out-of-pocket costs before their insurance coverage fully kicks in . For these individuals, TrumpRx can offer crucial short-term relief by slashing the immediate cost of a needed medication .

3. Patients with Uncovered Medications

Even with insurance, not all drugs are covered. If a patient’s health plan categorizes a necessary brand-name medication as non-formulary or excludes it entirely, TrumpRx can provide access to a discounted cash price when the patient would otherwise have to pay the full price .

You’re right to ask for the complete picture. The drug list has actually expanded significantly since the February 2026 launch. Here is the full list of medications currently available on TrumpRx, with their prices, organized by when they were added.

The Original 43 TrumpRx Drugs (Launched February 2026)

This is the initial list of brand-name medications that launched the platform, featuring drugs from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer . These agreements were the result of the administration’s Most-Favored-Nation (MFN) pricing policy, which aimed to match U.S. prices to the lowest paid in other developed nations .

Drug Name	Use	Original Price	TrumpRx Price
Abrilada	Biosimilar to Humira; treats rheumatoid arthritis, Crohn’s disease, psoriasis	$519.00	Starting at $207.60
Airsupra	Rescue inhaler for asthma	$503.93	$201.00
Azulfidine	Ulcerative colitis and rheumatoid arthritis	$199.20	Starting at $99.60
Azulfidine En-Tabs	Delayed-release sulfasalazine for ulcerative colitis and RA	$261.60	Starting at $130.80
Bevespi	Maintenance inhaler for COPD	$458.05	$51.00
Cetrotide	Fertility medication (prevents premature ovulation)	$316.12	$22.50
Chantix	Smoking cessation	$189.74	$94.87
Cleocin	Antibiotic (clindamycin)	$73.12	Starting at $36.56
Colestid	Lowers cholesterol	$135.60	Starting at $67.80
Cortef	Steroid (hydrocortisone)	$91.80	Starting at $45.90
Cytomel	Thyroid hormone (liothyronine)	$12.00	Starting at $6.00
Diflucan	Antifungal (fluconazole)	$28.12	$14.06
Duavee	Menopause symptom treatment and osteoporosis prevention	$202.00	$30.30
Estring	Vaginal estrogen ring for menopause symptoms	$577.18	$249.00
Eucrisa	Topical treatment for eczema	$792.40	$158.48
Farxiga	Type 2 diabetes, heart failure, CKD	$377.82	Starting at $181.59
Genotropin	Growth hormone therapy	$224.14	Starting at $89.67
Gonal-F	Fertility treatment (stimulates ovulation)	$966.04	Starting at $168.00
Insulin Lispro	Rapid-acting insulin for diabetes	Not listed	Starting at $25.00
Levoxyl	Thyroid hormone (levothyroxine)	$72.00	Starting at $36.00
Lopid	Lowers triglycerides (gemfibrozil)	$79.20	Starting at $39.60
Medrol	Steroid (methylprednisolone)	$6.30	Starting at $3.15
Ngenla	Weekly growth hormone injection	$4,434.20	Starting at $2,217.10
Nicotrol	Smoking cessation	$542.34	$271.17
Ovidrel	Fertility treatment (triggers ovulation)	$251.84	$84.00
Ozempic Pen	Type 2 diabetes	$1,027.51	Starting at $199.00
Premarin	Menopause symptom treatment	$217.86	$99.00
Premarin Vaginal Cream	Menopause symptom treatment	$473.30	$236.65
Prempro	Menopause symptom treatment	$254.30	Starting at $98.84
Pristiq	Antidepressant	$435.00	Starting at $200.10
Protonix	Treats stomach acid	$447.28	Starting at $200.10
Tikosyn	Treats irregular heartbeats	$672.00	Starting at $336.00
Toviaz	Overactive bladder	$290.00	Starting at $43.50
Vfend	Antifungal	$613.96	$306.98
Wegovy Pen	Weight loss	$1,349.00	Starting at $199.00
Wegovy Pill	Weight loss	$1,349.00	Starting at $149.00
Xeljanz	Autoimmune conditions	Not listed	Starting at $1,518.30
Zepbound	Weight loss	$1,088.00	Starting at $299.00
Zyvox	Antibiotic	Not listed	Starting at $122.74

Note on Pricing: Many drugs are listed with a “Starting at” price. The final cost can vary based on dosage strength . For example, Ozempic and Wegovy can be priced as low as the listed price, but average around $350 .

The First Major Expansion (March 2026)

By March, the platform had grown to 54 medications. This expansion included new agreements with Amgen, GSK, and Novartis, adding drugs for cholesterol, migraines, and respiratory conditions .

Drug Name	Use	Original Price	TrumpRx Price
Aimovig	Once-monthly injection to prevent migraines	Not listed	$783.02
Amjevita	Biosimilar to Humira; treats autoimmune conditions	$1,484.16	Starting at $299.00
Anoro Ellipta	COPD treatment	$489.09	Starting at $247.94
Arnuity Ellipta	Asthma treatment	$208.49	Starting at $102.98
Incruse Ellipta	COPD treatment	$354.10	Starting at $159.20
Mayzent	Relapsing forms of multiple sclerosis	$623.00	Starting at $42.00
Relenza	Treat and prevent influenza	$59.00	$52.90
Repatha	Lowers LDL cholesterol, reduces risk of heart attacks	$625.89	Starting at $239.00
Rydapt	Specific blood cancers (FLT3-mutated AML)	$13,411.00	Starting at $2,908.64
Tabrecta	Advanced/metastatic non-small cell lung cancer	$11,666.00	Starting at $2,649.92

Later Additions in 2026

Johnson & Johnson Additions (April 2026)

Johnson & Johnson joined the platform, adding these drugs :

Drug Name	Use	Original Price	TrumpRx Price
Invokana	Type 2 diabetes	$598.56	~$225.00
Invokamet XR	Type 2 diabetes (combination)	$598.56	~$225.00
Xarelto	Blood thinner	$611.82	~$197.00
Metformin / Metformin ER	Type 2 diabetes	Not listed	Not listed

Other Major Additions

Drug Name	Use	Original Price	TrumpRx Price
Epclusa	Hepatitis C treatment	~$25,000	$2,425.00
Humira	Autoimmune conditions (from AbbVie)	Not listed	$950.00 (86% discount)
Plavix	Blood thinner	$756.00	$16.00
Xofluza	Influenza treatment (from Genentech)	$168.00	$50.00
Various Insulin	Diabetes (from Sanofi)	Not listed	$35.00/month

The Massive Generic Expansion (August 2026)

In August 2026, the platform expanded dramatically by adding more than 600 generic medications . This was achieved through new partnerships with Mark Cuban Cost Plus Drugs, Amazon Pharmacy, and GoodRx .

• Common generics added: The new listings include widely prescribed therapies such as atorvastatin (cholesterol), clopidogrel (blood thinner), lisinopril (blood pressure), and metformin (diabetes) .
• Pricing: Many of these generics are priced under $5 .
• How it works: Rather than direct manufacturer deals, the TrumpRx website now links users to these external pharmacies for cash-pay pricing .

This expansion marks a shift from a platform that was initially brand-heavy to one that now offers high-volume, low-cost maintenance therapies . The TrumpRx platform has reportedly generated $700 million in savings for millions of American patients since its launch .

A Critical Note on Using TrumpRx

While the discounts are substantial, it’s critical to remember that TrumpRx is a cash transaction, completely outside of insurance. This means any money you spend does not count toward your annual deductible or out-of-pocket maximum .

For patients with standard insurance with a fixed copay, that copay will almost certainly be lower than the discounted TrumpRx cash price. The platform is primarily designed for uninsured patients or those without coverage for a specific medication .

The Catch: Why TrumpRx Might Not Be Right for You

Despite the significant discounts, TrumpRx has critical limitations that mean it is not a universal solution. For many Americans, using it could even be a financially detrimental decision .

The “Deductible Trap” for Insured Patients

The most significant financial detail of TrumpRx is that it operates as a cash transaction, entirely outside of insurance . This means the money you spend does not count toward your annual insurance deductible or out-of-pocket maximum.

• The Dilemma: Using a $199 TrumpRx coupon for a medication could save you $600 immediately compared to a $900 insurance price. However, you will have not made any progress toward meeting your deductible. If you later require a hospital stay or an expensive procedure, you will still be responsible for the full deductible amount .
• The Calculation: As Dr. Ashish Jha, former White House COVID-19 coordinator, noted, while uninsured patients will find the platform “really helpful,” insured patients with high-deductible plans face a complex calculation that depends on projecting their total health spending for the year . This makes it a risky choice for some.

The Medicare and Medicaid Exclusion

The program explicitly excludes the more than 140 million Americans enrolled in Medicare or Medicaid . This is a standard exclusion for manufacturer coupon programs, but it means the program cannot help the populations that most frequently rely on public insurance programs.

The Growing List of TrumpRx Discounted Drugs

The drug list is not static. While it launched with 43 drugs from five manufacturers, it has expanded to include over 66 medications from companies like Pfizer, Merck, and Novo Nordisk . The discounts range from 33% to more than 93% off the list price .

Here is the current list, organized by health condition, based on the most recent reporting :

Weight-Loss and Diabetes Drugs

• Ozempic pen: A popular medication for type 2 diabetes and weight loss .
• Wegovy pen and pill: A blockbuster weight-loss drug .
• Zepbound: A highly anticipated weight-loss medication .
• Farxiga: Used for type 2 diabetes, heart failure, and chronic kidney disease .
• Foundayo: A new addition to the weight-loss drug category .
• Insulin lispro: A fast-acting insulin for diabetes management .
• Jentadueto, Xigduo XR: Oral medications for type 2 diabetes .

Autoimmune and Inflammatory Conditions

This category features some of the most expensive biologic drugs, offering significant potential savings.

• Humira pen and syringe: A widely used treatment for various inflammatory conditions .
• Enbrel: Used for rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis .
• Otezla: For severe plaque psoriasis, psoriatic arthritis, and oral ulcers .
• Abrilada, Amjevita: Biosimilars used for rheumatoid arthritis and Crohn’s disease .
• Xeljanz, Zeposia: Used for autoimmune conditions and ulcerative colitis .
• Orencia: For moderate-to-severe rheumatoid arthritis and juvenile idiopathic arthritis .

Women’s Health and Fertility

• Premarin pill and vaginal cream: Hormone therapies for menopause symptoms .
• Prempro: Combination hormone therapy .
• Estring: A vaginal ring for menopausal symptoms .
• Duavee: Treats hot flashes and helps prevent osteoporosis .
• Diflucan: An antifungal medication .
• Gonal-F, Cetrotide, Ovidrel: A suite of drugs used to treat infertility and support fertility treatments .

Respiratory Conditions (Asthma and COPD)

• Airsupra: An inhaler for asthma .
• Bevespi Aerosphere, Anoro Ellipta, Incruse Ellipta: A variety of treatments for COPD .
• Arnuity Ellipta: For long-term asthma management .

Other Key Medications

• Chantix: A medication for smoking cessation .
• Zavzpret: A nasal spray for migraine treatment .
• Alphagan P: Prescription eye drops for high eye pressure in glaucoma patients .
• Colestid: For managing high cholesterol .

The Bigger Picture: Potential Impact on the Drug Industry

TrumpRx is not just a consumer tool; it represents a potential earthquake for the traditional pharmaceutical supply chain.

A Direct Challenge to Pharmacy Benefit Managers (PBMs)

PBMs, the powerful “middlemen” in the drug supply chain, negotiate rebates and manage formularies. However, TrumpRx bypasses them entirely by connecting manufacturers directly with patients . Health economist John C. Goodman argues that this could pressure the entire system.

“I think the pharmacies are going to lose out to the Mark Cubans, unless they can find a way to pass on the low price to the consumers,” he told Drug Topics, suggesting the traditional model faces obsolescence . While immediate financial impact on insurers may be low, the long-term challenge to their negotiating leverage could be profound .

The Strategic Shift for Pharma

For drug companies, TrumpRx offers a strategic double-win: tariff relief and a direct line to the consumer. This allows them to engage patients outside the traditional insurance and PBM system, gaining valuable data and control over the patient relationship . As one analyst put it, “If this is all that President Trump does on drug pricing, it is likely a win for the pharmaceutical industry” .

The Access Paradox

The program’s ultimate success may be limited not by price but by access to care. A critical blind spot of TrumpRx is that it does not solve the problem of diagnosis. A drug discount is irrelevant if a patient cannot see a doctor to get a prescription . As Pouria Sanae, writing in PharmExec, noted, affordability without access is only half of a solution .

Conclusion: A Targeted Tool, Not a Cure-All

TrumpRx is a significant and controversial initiative. For the uninsured and those with high deductibles who cannot otherwise afford their medications, it offers a practical and immediate lifeline. The list of discounted drugs is substantial and growing, covering high-cost areas like weight loss, diabetes, and autoimmune diseases .

However, it is not a “transformative” cure for the nation’s broader drug pricing problem. Its scope is too narrow to help everyone, and its structure creates a strategic dilemma for insured patients who must weigh immediate savings against the loss of progress toward their deductible. Its exclusion of Medicare and Medicaid patients leaves the most vulnerable out of the equation .

Ultimately, TrumpRx represents a powerful new tool in a complex healthcare system. It has the potential to help millions in dire need, but it requires a new level of consumer financial literacy to navigate its choices effectively. For the average patient, the decision to use TrumpRx should be made carefully, comparing the discounted cash price against their insurance copay and carefully projecting their annual healthcare expenses .